Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes With Non-alcoholic Fatty Liver (NAFLD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03233178
What this trial is testing

Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)Fatty LiverNAFLD
LMC Diabetes & Endocrinology Ltd. 4,000
Not applicableStudy completedNCT07269197
What this trial is testing

Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2
Josip Juraj Strossmayer University of Osijek 67
Post-approval studies (Phase 4)Study completedNCT03646292
What this trial is testing

Antidiabetic Drugs for Steatotic Liver Disease

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseType 2 DiabetesDigestive System Disease+11 more
Yonsei University 51
Not applicableStudy completedNCT03847116
What this trial is testing

Alcohol Consumption and Type 2 Diabetes Mellitus Risk in Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseaseLight-to-moderate Alcohol ConsumptionType2 Diabetes Mellitus
Ningbo No. 1 Hospital 14,014
Not applicableStudy completedNCT03447964
What this trial is testing

Plasma Dihydroceramides Are Associated With Hepatic Steatosis in Type 1 and Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Groupe Hospitalier Pitie-Salpetriere 128
Not applicableLooking for participantsNCT06138821
What this trial is testing

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

Who this might be right for
ObesityLiver DiseasesLiver Fibrosis+16 more
Pichamol Jirapinyo, MD, MPH 132
Testing effectiveness (Phase 2)Study completedNCT01399645
What this trial is testing

Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic SteatohepatitisType 2 Diabetes
Centre hospitalier de l'Université de Montréal (CHUM) 35
Very early researchNot Yet RecruitingNCT07198516
What this trial is testing

The Improvement Effect of Henggliejin on Fatty Liver in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver:

Who this might be right for
NAFLDDiabete Type 2
Fujian Medical University Union Hospital 149
Not applicableStudy completedNCT04232293
What this trial is testing

Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2NAFLDNASH
Nantes University Hospital 722
Post-approval studies (Phase 4)Study completedNCT03796975
What this trial is testing

Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver Disease

Who this might be right for
Type 2 Diabetes MellitusNon-alcoholic Fatty Liver DiseaseEfficacy
Xijing Hospital 120
Testing effectiveness (Phase 2)Study completedNCT03656744
What this trial is testing

HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Fatty Liver, NonalcoholicNAFLDNonalcoholic Fatty Liver Disease+3 more
HighTide Therapeutics (Hong Kong) Limited 101
Post-approval studies (Phase 4)Study completedNCT02285205
What this trial is testing

A 24 Week, Multicenter, Prospective, Open-labeled, Single-arm, Exploratory Phase 4 Clinical Trial to Evaluate the Safety and Efficacy of Lobeglitazone in Decreasing Intrahepatic Fat Contents in Type 2 Diabetes With NAFLD

Who this might be right for
Type 2 DiabetesNon-alcoholic Fatty Liver Disease
Yonsei University 38
Not applicableActive Not RecruitingNCT04114682
What this trial is testing

Longitudinal Assessment of Multiple Organs in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Perspectum 135
Not applicableEnrolling By InvitationNCT06895018
What this trial is testing

Medium-term Effects of a Polyphenol-rich Beverage Based on Red Grape Pomace Extract on Non-alcoholic Fatty Liver Disease, Cardiometabolic Risk Profile and Gut Microbiota in Subjects with Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2
Federico II University 20
Post-approval studies (Phase 4)Study completedNCT02147925
What this trial is testing

Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects

Who this might be right for
Non-alcoholic Fatty Liver Disease
Sun Yat-sen University 75
Testing effectiveness (Phase 2)Study completedNCT04616014
What this trial is testing

Oral Insulin to Reduce Liver Fat Content in Type 2 Diabetes Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Oramed, Ltd. 7
Not applicableStudy completedNCT03060694
What this trial is testing

Screening Diabetes Patients for NAFLD With Controlled Attenuation Parameter and Liver Stiffness Measurements

Who this might be right for
Non-alcoholic Fatty Liver Disease
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 58
Not applicableStudy completedNCT00230087
What this trial is testing

Iron Depletion Therapy for Type 2 DM and NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDiabetes Mellitus
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 15
Not applicableLooking for participantsNCT07083336
What this trial is testing

Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease (Version 3.0)

Who this might be right for
Type 2 Diabetes MellitusMetabolic Dysfunction-associated Steatotic Liver Disease
State Key Laboratory of Subhealth Intervention Technology 120
Not applicableUnknownNCT02285218
What this trial is testing

Role of New Adipokines and Hepatokines in Prediction of Patients With Metabolic Syndrome or NAFLD

Who this might be right for
Non-alcoholic Fatty Liver DiseaseType 2 DiabetesMetabolic Syndrome
Yonsei University 200
Next Page